Acute murine cytomegalovirus infection: A model for determining antiviral activity against CMV induced hepatitis

Antiviral Research

Volumn 44, Issue 3, 1999, Pages 155-165

  Bolger, Gordon ^a   Lapeyre, Nicole ^a   Rhéaume, Manon ^a   Kibler, Philip ^a   Bousquet, Christiane ^a   Garneau, Michel ^a   Cordingley, Michael ^a  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

Cytomegalovirus; Hepatitis; Mouse; Transaminase

Indexed keywords

ALANINE AMINOTRANSFERASE; CIDOFOVIR; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEPATITIS; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ALANINE TRANSAMINASE; ANIMALS; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CYTOMEGALOVIRUS INFECTIONS; CYTOSINE; DISEASE MODELS, ANIMAL; FEMALE; GANCICLOVIR; HEPATITIS, VIRAL, ANIMAL; HERPESVIRIDAE INFECTIONS; LIVER; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; VIRUS REPLICATION;

EID: 0033399001     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00063-7     Document Type: Article

References (37)

1. Abe K, Inchauspe G., Shikata T., Prince A.M. Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology. 4:1992;690-695.
2. Alford C.A., Britt W.J. Cytomegalovirus. Fields B.N., Knipe D.M. et al. Virology. 1990;1981-2010 Raven Press Limited, New York.
3. Amador E., Massod M.F., Franley R.J. Reliability of glutamic-oxalacetic transaminase methods. Am. J. Clin. Pathol. 47:1967;419-428.
4. Barnard D.L. et al. Selective inhibition of cytomegaloviruses by 9-(3′-ethylphosphono-1′-hydroxymethyl-1′-propyloxy-methyl) guanine. Antiviral Res. 22:1993;77-89.
5. Betts R.F. Cytomegalovirus in the compromised host(s). Ann. Rev. Med. 28:1997;103-110.
6. Collier A.C., Corey L. Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal. Cur. Clin. Top. Infect. Dis. 12:1992;309-328.
7. Bogin E., Peh H.C., avidar Y., Israeli B.A., Kahaner A. The effects of long term high environmental temperature on cellular enzyme activities from different organs. Eur. J. Clin. Chem. Biochem. 34:1996;625-629.
8. Collins T., Pomeroy C., Jordan M.C. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168:1993;725-729.
9. Drew W.L. Cytomegalovirus infection in patients with AIDS. J. Infect. Dis. 158:1988;449-456.
10. Eddleston M., Peacock S., Juniper M., Warrel D.A. Severe cytomegalovirus infection in immunocompetent patients. Clin. Infect. Dis. 24:1997;52-56.
11. Houghton M. Hepatitis C viruses. Fields B.N., Knipe P.M., Howley P.M. Virology. 1996;1035-1058 Lippincott-Raven, New York.
12. Karwinski W., Garcia R., Helton W.S. Allopurinol dose is important for attenuation of liver dysfunction after normothermic ischemia: correlation between bile flow and liver enzymes in circulation. Res. Exp. Med. 194:1994;321-328.
13. Katzenstein D.A., Yu G.S.M., Jordan M.C. Lethal infection with murine cytomegalovirus after early viral replication in the spleen. J. Infect. Dis. 148:1983;406-411.
14. Laing R.B., Dykhuizen R.S., Smith C.C., Molyneaux P.J. Parenteral ganciclovir treatment of acute CMV infection in the immunocompetent host. Infection. 25:1997;44-46.
15. Lea A.P., Bryson H.M. Cidovofir. Drugs. 52:1996;225-230.
16. Leman J.S., Toalson T.W., Wlodaver C.G. Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host. J. Oklahoma State Med. Assoc. 90:1997;367-369.
17. Lussier G. Murine cytomegalovirus (MCMV). Adv. Veterinary Sci. Comp. Med. 19:1975;223-247.
18. Miguelez M, Gonzalez A., Perez F. Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir. Scand. J. Infect. Dis. 30:1998;304-305.
19. Mims C.A., Gould J. Splenic necrosis in mice infected with cytomegalovirus. J. Infect. Dis. 137:1978;587-591.
20. Nedrud J.G., Collier A.M., Pagano J.S. Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture. J. Gen. Virol. 45:1979;737-744.
21. Neyts J., Balzarini J., Naesens L., De Clercq E. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. J. Med. Virol. 37:1992;67-71.
22. Neyts, J. Sobis, H., Snoeck, R., Vandeputte, De Clercq, E. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethyoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propxymethyl)guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Eur. J. Clin. Microbiol. Infec. Dis. 12:269-279, 1993.
23. Noble S., Faulds D. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs. 56:1998;115-146.
24. Osborn J.E. Cytomegalovirus and other herpesviruses. Foster H.L., Small J.D., Fox J.G. The Mouse in Biomedical Research. 1982;267-292 Academic Press, New York.
25. Pollard R. Cytomegalovirus infections in renal, heart, heart-lung, and liver transplantation. Pediatr. Infect. Dis. J. 7S:1988;91S-102S.
26. Reitman S., Frankel S. A colorometric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28:1957;56-63.
27. Selgrade M.J.K., Osborn J.E. Divergence of mouse brain interferon responses following virulent or avirulent newcastle disease virus inoculation. Proc. Soc. Biol. Med. 143:1973;12-18.
28. Shanley J.D., Pesanti E.L. Murine cytomegalovirus adrenalitis in athymic nude mice. Arch. Virol. 88:1986;27-35.
29. Shanley J.D., Biczak L, Forman S.J. Acute murine cytomegalovirus infections induces lethal hepatitis. J. Infect. Dis. 167:1993;264-269.
30. Shindo M., Di Bisceglie A.M., Biswas R., Mihalik K., Feinstone S.M. Hepatitis C virus replication during acute infection in the chimpanzee. J. Infect. Dis. 166:1992;424-427.
31. Sissons J.G.P. The immunology of cytomegalovirus infection. J. Royal College Physicians London. 20:1986;40-44.
32. Smee D.F., Pease A., Burger R.A., Huffman J.H., Morrey J.D., Okleberry K.M., Noble R.L., Sidwell R.W. Ganciclovir treatment of murine cytomegalovirus infection in mice immunosuppressed by prior infection with Friend leukemia virus. Antivir. Chem. Chemo. 3:1992;327-333.
33. Staczek J.T. Animal cytomegaloviruses. Microbiol. Rev. 54:1990;247-265.
34. Stinski M.F. Cytomegalovirus and its replication. Fields B.N., Knipe J.R. et al. Virology. 1990;1959-1980 Raven Press, New York.
35. Trgovcich, J., Polic, S.B., Zorcia, I., Pavic, C.I., Koszinowski. U.S. Jonjic, S. Perturbation of liver function in MCMV-induced hepatitis. Abst 133, 6th International Cytomegalovirus Workshop, p A-67, 1997.
36. van der Meer J.T.M. et al. Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antivir. Res. 32:1996;119-140.
37. Williams-Blangero S., Blangero J., Murthy K.K., Lanford R.E. Genetic analysis of serum alanine transaminase activity in normal and hepatitis C virus-infected chimpanzees: an application of research-oriented genetic management. Lab. Animal Sci. 46:1996;26-30.